these medicines are used alone or in combination with other injectables or tablets, particularly metformin, which help the pancreas make more insulin and use it better. also, sulfonylureas cause weight gain and metformin causes weight loss, so they balance each other out somewhat.
sodium glucose transporter 2 inhibitors (sglt2)
these drugs include canagliflozin, dapagliflozin and empagliflozin and are designed to remove excess sugar from the body through the urine, according to
health canada. they are used alone or in combination with other similar drugs, alongside diet and exercise.
health canada reviewed these drugs after they were thought to increase the risk of diabetic ketoacidosis, which happens when ketones, a type of bodily waste, builds up to toxic levels in the blood. despite the risk, the study concluded that the benefits outweighed the risks.
glp-1 receptor agonists (glucagon-like peptide-1)
the most widely known of this class of drugs, ozempic and wegovy, are semaglutides and are basically the same drug, says senior. ozempic is used to treat type 2 diabetes, and often covered by provincial health plans, and wegovy is used for management of obesity, which often is not.